Boehringer Ingelheim exits Hikma Pharmaceuticals
German pharmaceuticals company Boehringer Ingelheim has sold its remaining stake in UK drug maker Hikma Pharmaceuticals, after a surge in investor interest in pharma stocks during the Covid-19 global pandemic.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: